Speciality: Anesthesia
Description:
In today’s episode, let’s explore the differences between regional and general anesthesia. Regional anesthesia numbs a specific part of the body, such as during spinal or epidural procedures, allowing patients to remain awake but comfortable. This method often leads to quicker recovery times and fewer side effects like nausea. General anesthesia, on the other hand, puts the entire body into a sleep-like state, making the patient completely unaware and pain-free during surgery. While it’s essential for major operations, it can come with longer recovery and more side effects. Choosing between them depends on the type of surgery, patient health, and personal preference. Understanding these options helps you make informed decisions about your care.
See More Webinars @ Hidoc Webinars
1.
Microplastics can cause malignant changes in lung cells
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
4.
Rural residents continue to have higher odds of skin cancer, study finds
5.
Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer
1.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
2.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
3.
Innovative Approaches in Oncology for Modern Medicine
4.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
5.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Screening in Cancer Prevention
2.
From Guidelines to Practice: Hematology
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Navigating the Complexities of Ph Negative ALL - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation